Skip to main navigation Skip to search Skip to main content

A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer

  • Tatiana Shaurova
  • , Lingyue Yan
  • , Yafei Su
  • , Laurie James Rich
  • , Vui King Vincent-Chong
  • , Hannah Calkins
  • , Saraswati Pokharel
  • , Martin Petkovich
  • , Mukund Seshadri
  • , Yun Wu
  • , Pamela Anne Hershberger
  • Roswell Park Cancer Institute
  • SUNY Buffalo
  • Fujifilm-VisualSonics Corporation
  • Queen's University Kingston

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish
Pages (from-to)503-507
Number of pages5
JournalCancer Communications
Volume43
Issue number4
DOIs
StatePublished - Apr 2023

Fingerprint

Dive into the research topics of 'A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer'. Together they form a unique fingerprint.

Cite this